MedPath

Physostigmine Salicylate

Physostigmine Salicylate Injection

Approved
Approval ID

a7d04b2c-fe34-480d-8f7c-7cbcf447a70b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 13, 2022

Manufacturers
FDA

Akorn

DUNS: 117693100

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Physostigmine Salicylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17478-510
Product Classification
G
Generic Name
Physostigmine Salicylate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 15, 2010
FDA Product Classification

INGREDIENTS (4)

waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium metabisulfiteInactive
Code: 4VON5FNS3C
Classification: IACT
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT
physostigmine salicylateActive
Quantity: 1 mg in 1 mL
Code: 2046ZRO9VU
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Physostigmine Salicylate - FDA Drug Approval Details